+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer's disease



The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer's disease



Acta Neuropathologica Communications 7(1): 13



The adipocyte plasma membrane-associated protein APMAP is expressed in the brain where it associates with γ-secretase, a protease responsible for the generation of the amyloid-β peptides (Aβ) implicated in the pathogenesis of Alzheimer's disease (AD). In this study, behavioral investigations revealed spatial learning and memory deficiencies in our newly generated mouse line lacking the protein APMAP. In a mouse model of AD, the constitutive deletion of APMAP worsened the spatial memory phenotype and led to increased Aβ production and deposition into senile plaques. To investigate at the molecular level the neurobiological functions of APMAP (memory and Aβ formation) and a possible link with the pathological hallmarks of AD (memory impairment and Aβ pathology), we next developed a procedure for the high-grade purification of cellular APMAP protein complexes. The biochemical characterization of these complexes revealed a series of new APMAP interactomers. Among these, the heat shock protein HSPA1A and the cation-dependent mannose-6-phosphate receptor (CD-M6PR) negatively regulated APP processing and Aβ production, while clusterin, calnexin, arginase-1, PTGFRN and the cation-independent mannose-6-phosphate receptor (CI-M6PR/IGF2R) positively regulated APP and Aβ production. Several of the newly identified APMAP interactomers contribute to the autophagy-lysosome system, further supporting an emergent agreement that this pathway can modulate APP metabolism and Aβ generation. Importantly, we have also demonstrated increased alternative splicing of APMAP and lowered levels of the Aβ controllers HSPA1A and CD-M6PR in human brains from neuropathologically verified AD cases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446611

Download citation: RISBibTeXText

PMID: 30704515

DOI: 10.1186/s40478-019-0660-3


Related references

Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Neurobiology of Disease 37(3): 682-691, 2010

Altered processing characteristics of beta-amyloid-containing peptides in cytosol and in media of familial Alzheimer's disease cells. Biochimica et Biophysica Acta 1225(3): 304-310, 1994

Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal. Drug Discovery Today 22(2): 223-233, 2016

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD). Expert Opinion on Emerging Drugs 13(2): 255-271, 2008

Preclinical to phase II amyloid beta (A β ) peptide modulators under investigation for Alzheimer's disease. Expert Opinion on Investigational Drugs 26(5): 579-592, 2017

Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opinion on Emerging Drugs 2012, 2012

Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease. Annals of the New York Academy of Sciences 695: 103-108, 1993

Altered amyloid protein processing in platelets of patients with Alzheimer disease. Archives of Neurology 54(2): 139-144, 1997

The amyloid beta protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition. Tohoku Journal of Experimental Medicine 174(3): 217-223, 1994

Processing of Alzheimer A beta-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease. International Review of Neurobiology 36: 29-50, 1994

Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease. Stem Cell Reports 8(4): 870-882, 2017

Alzheimer's disease amyloid precursor protein (ApPP): proteolytic processing, secretases and βA4 amyloid production. Amyloid 1(4): 263-280, 1994

The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease. Biochimica et Biophysica Acta. Biomembranes 2019, 2019

Altered processing characteristics of β-amyloid-containing peptides in cytosol and in media of familial Alzheimer's disease cells. Biochimica et Biophysica Acta - Molecular Basis of Disease 1225(3): 304-310, 1994

Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease. PharmacoTherapy 22(12): 1547-1563, 2002